IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
India |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Bangladesh en nombre de Países menos adelantados |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Brasil |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Sudáfrica |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
China |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Indonesia |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Nigeria en nombre de African Group |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Egipto |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Estados Unidos de América |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Japón |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Canadá |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Corea, República de |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Noruega |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Unión Europea |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Suiza |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Australia |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Taipei Chino |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Chile |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Brasil |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
World Health Organization (WHO) |
01/03/2017-02/03/2017 |
07/06/2017 |
|